A case of livedoid vasculopathy associated with factor V Leiden mutation: Successful treatment with oral warfarin

Journal of Dermatological Treatment

Volumn 19, Issue 2, 2008, Pages 121-123

  Kavala, Mukaddes ^a   Kocatürk, Emek ^a   Zindanci, Ilkin ^a   Türkoǧlu, Zafer ^a   Altintaş, Sümeyye ^a  

^a GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Factor V Leiden mutation; Livedoid vasculopathy; Oral warfarin

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; STEROID; WARFARIN;

ADULT; ARTICLE; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEG ULCER; LIVEDOID VASCULOPATHY; MALE; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCAR; SKIN BIOPSY; VASCULAR DISEASE;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; FACTOR V; HUMANS; LEG ULCER; MALE; MUTATION; SKIN DISEASES, VASCULAR; WARFARIN;

EID: 45949097812     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630701670305     Document Type: Article

References (8)

1. Papi M, Didona B, De Pita O, Frezzolini A, Di Giulio S, De Matteis W, et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: Cytokine and platelet P-selectin studies. Arch Dermatol. 1998;134:447-52.
2. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation. J Am Acad Dermatol. 2002;46:133-7.
3. Jorizzo JL. Livedoid vasculopathy: What is it? Arch Dermatol. 1998;134:491-3.
4. Wakelin SH, Ellis JP, Black MM. Livedoid vasculitis with anticardiolipin antibodies: Improvement with danazol. Br J Dermatol. 1998;139:935-7.
5. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: A manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999;140:131-5.
6. Boyvat A, Kundakci N, Babikir MO, Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol. 2000;143:840-2.
7. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag NH, Neumann HA. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol. 1999;135:41-4.
8. Federman DG, Kirsner RS. An update on hypercoagulable disorders. Arch Intern Med. 2001;161:1051-6